New-onset atrial fibrillation and acute coronary syndrome

References

• Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am. J. Med.98, 476–484 (1995).
   PubMed Web of Science ®Google Scholar
• Cristal N, Szwarcberg J, Gueron M. Supraventricular arrhythmias in acute myocardial infarction. Prognostic importance of clinical setting; mechanism of production. Ann. Intern. Med.82, 35–39 (1975).
   PubMedGoogle Scholar
• Hunt D, Sloman G, Penington C. Effects of atrial fibrillation on prognosis of acute myocardial infarction. Br. Heart J.40, 303–307 (1978).
   PubMedGoogle Scholar
• Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur. Heart J.13, 45–50 (1992).
   PubMed Web of Science ®Google Scholar
• Sakata K, Kurihara H, Iwamori K et al. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am. J. Cardiol.80, 1522–1527 (1997).
   PubMed Web of Science ®Google Scholar
• Crenshaw BS, Ward SR, Granger CB et al. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J. Am. Coll. Cardiol.30, 406–413 (1997).
   PubMed Web of Science ®Google Scholar
• Wong CK, White HD, Wilcox RG et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am. Heart J.140, 878–885 (2000).
   PubMed Web of Science ®Google Scholar
• Rathore SS, Berger AK, Weinfurt KP et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation101, 969–974 (2000).
   PubMed Web of Science ®Google Scholar
• Pizzetti F, Turazza FM, Franzosi MG et al. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart86, 527–532 (2001).
   PubMed Web of Science ®Google Scholar
• Goldberg RJ, Yarzebski J, Lessard D, Wu J, Gore JM. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. Am. Heart J.143, 519–527 (2002).
   PubMed Web of Science ®Google Scholar
• Asanin M, Perunicic J, Mrdovic I et al. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur. J. Heart Fail.7, 671–676 (2005).
   PubMed Web of Science ®Google Scholar
• Kober L, Swedberg K, McMurray JJ et al. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur. J. Heart Fail.8, 591–598 (2006).
   PubMed Web of Science ®Google Scholar
• Saczynski JS, McManus D, Zhou Z et al. Trends in atrial fibrillation complicating acute myocardial infarction. Am. J. Cardiol.104, 169–174 (2009).
   PubMedGoogle Scholar
• Mehta RH, Dabbous OH, Granger CB et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am. J. Cardiol.92, 1031–1036 (2003).
   PubMed Web of Science ®Google Scholar
• Lau DH, Huynh LT, Chew DP et al. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am. J. Cardiol.104, 1317–1323 (2009).
   PubMed Web of Science ®Google Scholar
• Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. Trandolapril Cardiac Evaluation. Eur. Heart J.20, 748–754 (1999).
   PubMed Web of Science ®Google Scholar
• Eldar M, Canetti M, Rotstein Z et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation97, 965–970 (1998).
   PubMed Web of Science ®Google Scholar
• Aronson D, Boulos M, Suleiman A et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am. J. Cardiol.100, 753–757 (2007).
   PubMed Web of Science ®Google Scholar
• Hwang HJ, Ha JW, Joung B et al. Relation of inflammation and left atrial remodeling in atrial fibrillation occurring in early phase of acute myocardial infarction. Int. J. Cardiol. DOI: 10.1016/j.ijcard.2009.05.065 (2009) (Epub ahead of print).
   Google Scholar
• Siu CW, Jim MH, Ho HH et al. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest132, 44–49 (2007).
   PubMedGoogle Scholar
• Asanin MR, Vasiljevic ZM, Matic MD et al. The long-term risk of stroke in patients with acute myocardial infarction complicated with new-onset atrial fibrillation. Clin. Cardiol.32, 467–470 (2009).
   PubMedGoogle Scholar
• Asanin M, Vasiljevic Z, Matic M et al. Outcome of patients in relation to duration of new-onset atrial fibrillation following acute myocardial infarction. Cardiology107, 197–202 (2007).
   PubMedGoogle Scholar
• Sinno H, Derakhchan K, Libersan D et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation107, 1930–1936 (2003).
   PubMed Web of Science ®Google Scholar
• Nielsen FE, Andersen HH, Gram-Hansen P, Sorensen HT, Klausen IC. The relationship between ECG signs of atrial infarction and the development of supraventricular arrhythmias in patients with acute myocardial infarction. Am. Heart J.123, 69–72 (1992).
   PubMed Web of Science ®Google Scholar
• Shakir DK, Arafa SO. Right atrial infarction, atrial arrhythmia and inferior myocardial infarction form a missed triad: a case report and review of the literature. Can. J. Cardiol.23, 995–997 (2007).
   PubMedGoogle Scholar
• Sanders P, Morton JB, Davidson NC et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation108, 1461–1468 (2003).
   PubMed Web of Science ®Google Scholar
• Rechavia E, Strasberg B, Mager A et al. The incidence of atrial arrhythmias during inferior wall myocardial infarction with and without right ventricular involvement. Am. Heart J.124, 387–391 (1992).
   PubMedGoogle Scholar
• Sugiura T, Iwasaka T, Takahashi N et al. Factors associated with atrial fibrillation in Q wave anterior myocardial infarction. Am. Heart J.121, 1409–1412 (1991).
   PubMed Web of Science ®Google Scholar
• Tofler GH, Muller JE, Stone PH et al. Pericarditis in acute myocardial infarction: characterization and clinical significance. Am. Heart J.117, 86–92 (1989).
   PubMedGoogle Scholar
• Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation96, 1686–1695 (1997).
   PubMed Web of Science ®Google Scholar
• Olgin JE, Sih HJ, Hanish S et al. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation98, 2608–2614 (1998).
   PubMed Web of Science ®Google Scholar
• Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J. Cardiovasc. Electrophysiol.7, 833–842 (1996).
   PubMed Web of Science ®Google Scholar
• Wichmann J, Ertl G, Rudolph G, Kochsiek K. Effect of experimentally induced atrial fibrillation on coronary circulation in dogs. Basic Res. Cardiol.78, 473–491 (1983).
   PubMedGoogle Scholar
• White CW, Holida MD, Marcus ML. Effects of acute atrial fibrillation on the vasodilator reserve of the canine atrium. Cardiovasc. Res.20, 683–689 (1986).
   PubMed Web of Science ®Google Scholar
• Kochiadakis GE, Skalidis EI, Kalebubas MD et al. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur. Heart J.23, 734–741 (2002).
   PubMedGoogle Scholar
• Ariyarajah V, Malinski M, Khadem A et al. Relation of recurrence of atrial fibrillation after non-ST-elevation acute myocardial infarction to left atrial abnormality. Am. J. Cardiol.101, 30–34 (2008).
   PubMedGoogle Scholar
• Asanin M, Perunicic J, Mrdovic I et al. Significance of recurrences of new atrial fibrillation in acute myocardial infarction. Int. J. Cardiol.109, 235–240 (2006).
   PubMedGoogle Scholar
• Connolly S, Pogue J, Hart R et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet367, 1903–1912 (2006).
   PubMed Web of Science ®Google Scholar
• Stenestrand U, Lindback J, Wallentin L. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Circulation112, 3225–3231 (2005).
   PubMedGoogle Scholar
• Depta JP, Cannon CP, Fonarow GC et al. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes. Am. J. Cardiol.104, 1171–1178 (2009).
   PubMed Web of Science ®Google Scholar
• Wang TY, Robinson LA, Ou FS et al. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry. Am. Heart J.155, 361–368 (2008).
   PubMed Web of Science ®Google Scholar
• Rubboli A, Colletta M, Sangiorgio P, Di Pasquale G. Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice. Ital. Heart J.5, 851–856 (2004).
   PubMedGoogle Scholar
• Sourgounis A, Lipiecki J, Lo TS, Hamon M. Coronary stents and chronic anticoagulation. Circulation119, 1682–1688 (2009).
   PubMedGoogle Scholar
• Rossini R, Musumeci G, Lettieri C et al. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am. J. Cardiol.102, 1618–1623 (2008).
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Porela P, Ylitalo A et al. Safety and efficacy of combined antiplatelet–warfarin therapy after coronary stenting. Eur. Heart J.28, 726–732 (2007).
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Kereiakes DJ, Kleiman NS et al. Combining antiplatelet and anticoagulant therapies. J. Am. Coll. Cardiol.54, 95–109 (2009).
   PubMed Web of Science ®Google Scholar
• Rubboli A, Halperin JL, Airaksinen KE et al. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann. Med.40, 428–436 (2008).
   PubMed Web of Science ®Google Scholar
• Zinn A, Feit F. Optimizing antithrombotic strategies in patients with concomitant indications for warfarin undergoing coronary artery stenting. Am. J. Cardiol.104, 49C–54C (2009).
   PubMedGoogle Scholar
• Lip GY, Huber K, Andreotti F et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Thromb. Haemost.103, 13–28 (2010).
   PubMed Web of Science ®Google Scholar
• Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med.347, 1825–1833 (2002).
   PubMed Web of Science ®Google Scholar
• Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation – Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet356, 1789–1794 (2000).
   PubMed Web of Science ®Google Scholar
• Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N. Engl. J. Med.347, 1834–1840 (2002).
   PubMed Web of Science ®Google Scholar
• Corley SD, Epstein AE, DiMarco JP et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation109, 1509–1513 (2004).
   PubMed Web of Science ®Google Scholar
• Wong CK, White HD, Wilcox RG et al. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries. Heart88, 357–362 (2002).
   PubMed Web of Science ®Google Scholar
• Kilborn MJ, Rathore SS, Gersh BJ, Oetgen WJ, Solomon AJ. Amiodarone and mortality among elderly patients with acute myocardial infarction with atrial fibrillation. Am. Heart J.144, 1095–1101 (2002).
   PubMedGoogle Scholar
• Kontoyannis DA, Anastasiou-Nana MI, Kontoyannis SA, Zaga AK, Nanas JN. Intravenous amiodarone decreases the duration of atrial fibrillation associated with acute myocardial infarction. Cardiovasc. Drugs Ther.15, 155–160 (2001).
   PubMedGoogle Scholar
• Julian DG, Camm AJ, Frangin G et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet349, 667–674 (1997).
   PubMed Web of Science ®Google Scholar
• Singh D, Cingolani E, Diamond GA, Kaul S. Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium? J. Am. Coll. Cardiol.55, 1569–1576 (2010).
   PubMed Web of Science ®Google Scholar
• Kober L, Bloch Thomsen PE, Moller M et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet356, 2052–2058 (2000).
   PubMed Web of Science ®Google Scholar
• Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N. Engl. J. Med.324, 781–788 (1991).
   PubMed Web of Science ®Google Scholar
• McMurray J, Kober L, Robertson M et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J. Am. Coll. Cardiol.45, 525–530 (2005).
   PubMed Web of Science ®Google Scholar
• McCullough PA, Sandberg KR, Borzak S et al. Benefits of aspirin and β-blockade after myocardial infarction in patients with chronic kidney disease. Am. Heart. J.144, 226–232 (2002).
   PubMed Web of Science ®Google Scholar
• Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation100, 376–380 (1999).
   PubMed Web of Science ®Google Scholar
• Fauchier L, Pierre B, de Labriolle A et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J. Am. Coll. Cardiol.51, 828–835 (2008).
   PubMed Web of Science ®Google Scholar
• Sakabe M, Shiroshita-Takeshita A, Maguy A et al. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation116, 2101–2109 (2007).
   PubMed Web of Science ®Google Scholar
• Laurent G, Moe G, Hu X et al. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc. Res.77, 89–97 (2008).
   PubMedGoogle Scholar
• Mozaffarian D, Psaty BM, Rimm EB et al. Fish intake and risk of incident atrial fibrillation. Circulation110, 368–373 (2004).
   PubMed Web of Science ®Google Scholar
• Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation120, 2315–2321 (2009).
   PubMed Web of Science ®Google Scholar